Advice

Specialist commentators

Specialist commentators

The following clinicians contributed to this briefing:

  • Dr Paul Brennan, consultant in clinical genetics, Northern Genetics Service, and deputy clinical director of integrated laboratory medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust. Dr Brennan is clinical programme director for the North East & North Cumbria NHS Genomic Medicine Centre, with a specific remit around enrolment of cancer patients, including children, into the 100,000 Genomes Project.

  • Dr Mike Hubank, head of clinical genomics (research), The Royal Marsden NHS Foundation Trust. Dr Hubank has done occasional consultancy work for Roche Diagnostics (which provides reagents for the NGS panel). Dr Hubank joined the organisation which developed the original NGS panel technology; he is responsible for updating and implementing the panel and running it as part of the METEOR clinical trial and for other purposes at the Royal Marsden Hospital.

  • Professor Louis Chesler, consultant oncologist for paediatric cancer biology, the Centre for Molecular Pathology at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. No relevant conflicts of interest.

Additional reviewer:

  • Dr Angela Silmon, chief executive officer, NewGene. No relevant conflicts of interest.

The following patient organisations contributed to this briefing:

  • Christopher's Smile

  • An individual patient expert who is also a consumer member from the National Cancer Research Institute Children's Cancer & Leukaemia Clinical Studies Group

  • Abbie's Army.